Esperion Therapeutics, Inc. (ESPR)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 459.44M |
| Enterprise value | 501.82M |
| Trailing P/E | N/A |
| Forward P/E | 10.55 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.38 |
| Price/book (mrq) | 98.42 |
| Enterprise value/revenue | 2.18 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.02 |
| 52-week change 3 | 54.78% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 3.4000 |
| 52-week low 3 | 0.7000 |
| 50-day moving average 3 | 2.4348 |
| 200-day moving average 3 | 2.0942 |
Share statistics
| Avg vol (3-month) 3 | 8.32M |
| Avg vol (10-day) 3 | 5.05M |
| Shares outstanding 5 | 189.46M |
| Implied shares outstanding 6 | 189.46M |
| Float 8 | 164.17M |
| % held by insiders 1 | 0.52% |
| % held by institutions 1 | 69.18% |
| Shares short (15 Jul 2024) 4 | 39.42M |
| Short ratio (15 Jul 2024) 4 | 3.93 |
| Short % of float (15 Jul 2024) 4 | 20.86% |
| Short % of shares outstanding (15 Jul 2024) 4 | 20.80% |
| Shares short (prior month 14 Jun 2024) 4 | 24.89M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -37.65% |
| Operating margin (ttm) | 52.47% |
Management effectiveness
| Return on assets (ttm) | -6.94% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 229.74M |
| Revenue per share (ttm) | 1.83 |
| Quarterly revenue growth (yoy) | 466.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -34.56M |
| Net income avi to common (ttm) | -86.51M |
| Diluted EPS (ttm) | -0.9000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 226.61M |
| Total cash per share (mrq) | 1.2 |
| Total debt (mrq) | 548.87M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.22 |
| Book value per share (mrq) | -1.57 |
Cash flow statement
| Operating cash flow (ttm) | -27.3M |
| Levered free cash flow (ttm) | -45.36M |
© 2024 Yahoo. All rights reserved.